Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine

Fallopian Tube Cancer Clinical Trials

A listing of Fallopian Tube Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 Last 

Arizona

Research Site
Phoenix Arizona

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Research Site
Tucson Arizona

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

View More »

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Phoenix Arizona 85013

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Scottsdale Arizona

Patients are needed to participate in a clinical research study of MEK162, MEK inhibitor; oral and Paclitaxel, mitotic inhibitor; intravenous to evaluate Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Tucson Arizona 85710

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

University of Arizona Cancer Center
Tucson Arizona 85719

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

California

Research Site
Los Angeles California

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Research Site
Los Angeles California

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Research Site
Stanford California

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

View More »

Saint Jude Heritage Medical Center
Fullerton California 92835

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Saint Jude Heritage Medical Center
Fullerton California 92835

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

University of California Los Angeles
Los Angeles California 90404

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

UCSF
San Francisco California 94155

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

University of California, San Francisco
San Francisco California 94115

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Coastal Integrative Cancer Care
San Luis Obispo California 93422

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Coastal Integrative Cancer Care
San Luis Obispo California 93401

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Central Coast Medical Oncology
Santa Maria California 93454

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Central Coast Medical Oncology
Santa Maria California 93454

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

University of California Los Angeles (UCLA)
Santa Monica California 90404

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Stanford University
Stanford California 94305

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Colorado

Rocky Mountain Cancer Centers
Lakewood Colorado 80228

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Rocky Mountain Cancer Centers
Lakewood Colorado 80228

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Florida

Research Site
Sarasota Florida

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Research Site
Tampa Florida

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

View More »

Memorial Healthcare System
Hollywood Florida 33021

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Mayo Clinic Jacksonville
Jacksonville Florida 32224

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Florida Hospital
Orlando Florida 32804

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Sarah Cannon Research Institute
Sarasota Florida 34232

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Sarasota Florida 34239

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Tampa Florida 33612

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Georgia

Research Site
Atlanta Georgia

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Memorial University Medical Center
Savannah Georgia 31404

GOG 0273: Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer

Illinois

Research Site
Chicago Illinois

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Indiana

Research Site
Indianapolis Indiana

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

Research Site
Indianapolis Indiana

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

View More »

Lafayette Indiana

Patients are needed to participate in a clinical research study of MEK162, MEK inhibitor; oral and Paclitaxel, mitotic inhibitor; intravenous to evaluate Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Horizon BioAdvance
Lafayette Indiana 47905

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Maryland

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Baltimore Maryland 21237

Patients are needed to participate in a clinical research study evaluating LY2228820, Carboplatin, Placebo and Gemcitabine for the treatment of Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Johns Hopkins Universty
Baltimore Maryland 21287

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Johns Hopkins Kimmel Cancer Center
Baltimore Maryland 21287

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Massachusetts

Research Site
Boston Massachusetts

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

View More »

Dana-Farber Cancer Institute
Boston Massachusetts 02215

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Dana-Farber Cancer Institute
Boston Massachusetts 02215

A clinical trial seeking patients for a research study for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Carcinoma

Massachusetts General Hospital
Boston Massachusetts 02114

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Dana-Farber Cancer Institute
Boston Massachusetts 02115

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Michigan

Karmanos Cancer Institute
Detroit Michigan 48201

A clinical research study of Rucaparib for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Karmanos Cancer Institute - Wayne State University
Detroit Michigan 48201

Patients are needed to participate in a clinical research study evaluating Rucaparib and Placebo for the treatment of Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

Minnesota

Research Site
Minneapolis Minnesota

A Maintenance Study With Niraparib (a PARP inhibitor) Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer

View More »

Mayo Clinic
Rochester Minnesota 55905

Patients are needed to participate in a clinical research study of Alvimopan and Placebo to evaluate Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Mayo Clinic
Rochester Minnesota 55905

Patients are needed to participate in a clinical research study of Oral rucaparib to evaluate Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer or Peritoneal Cancer

First 1 2 3 4 5 6 7 Last